SG1002 and Catenated Divalent Organic Sulfur Compounds as Promising Hydrogen Sulfide Prodrugs

por Gojon, Gabriel, Morales, Guillermo A.
Publicado 2020

3-(Trimethyl­sil­yl)prop-2-ynyl p-toluene­sulfonate

por Schmitt, Devin C., Morales, Guillermo A., Fronczek, Frank R., Watkins, Steven F.
Publicado 2011

Design of thienopyranone-based BET inhibitors that bind multiple synthetic lethality targets

por Vann, Kendra R., Pal, Dhananjaya, Morales, Guillermo A., Burgoyne, Adam M., Durden, Donald L., Kutateladze, Tatiana G.
Publicado 2020

The BTK/PI3K/BRD4 axis inhibitor SRX3262 overcomes Ibrutinib resistance in mantle cell lymphoma

por Pal, Dhananjaya, Vann, Kendra R., Joshi, Shweta, Sahar, Namood E., Morales, Guillermo A., El-Gamal, Dalia, Kutateladze, Tatiana G., Durden, Donald L.
Publicado 2021

Gypsum-DL: an open-source program for preparing small-molecule libraries for structure-based virtual screening

por Ropp, Patrick J., Spiegel, Jacob O., Walker, Jennifer L., Green, Harrison, Morales, Guillermo A., Milliken, Katherine A., Ringe, John J., Durrant, Jacob D.
Publicado 2019

A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity

por Burgoyne, Adam M., Vann, Kendra R., Joshi, Shweta, Morales, Guillermo A., Vega, Francisco M., Singh, Alok, Pal, Dhananjaya, Merati, Aran B., Kutateladze, Tatiana G., Durden, Donald L.
Publicado 2020

PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma

por Singh, Alok R., Joshi, Shweta, Zulcic, Muamera, Alcaraz, Michael, Garlich, Joseph R., Morales, Guillermo A., Cho, Yoon J., Bao, Lei, Levy, Michael L., Newbury, Robert, Malicki, Denise, Messer, Karen, Crawford, John, Durden, Donald L.
Publicado 2016